ENTITY
Yichang HEC Changjiang Pharma

Yichang HEC Changjiang Pharma (1558 HK)

122
Analysis
Health Care • Hong Kong
YiChang HEC ChangJiang Pharmaceutical Co Ltd develops a variety of drugs. The Company develops and sells drugs for anti-virus, metabolic diseases, cardiovascular, and more.
more
bullish•Xiaomi
•07 Oct 2019 09:20

Hong Kong Buyback Weekly: Xiaomi Led the Buybacks (2019-10-04)

Hong Kong Exchange publishes share repurchases by listed companies on a daily basis. In our weekly note, we will provide statistics on top...

Logo
474 Views
Share
•19 Aug 2019 13:59

HK Connect Ideas: Highlight of Hang Seng Quarterly Review (2019-08-16)

In our weekly HK Connect Snippet series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as...

Logo
584 Views
Share
bullish•Tencent
•12 Aug 2019 11:10

HK Connect Ideas: Tencent Newsflow Before Earnings, Strong Southbound Flows (2019-08-09)

In our weekly HK Connect Snippet series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as...

Logo
556 Views
Share
bullish•Anta Sports Products
•22 Jul 2019 11:39

HK Connect Ideas: Ten Weeks of Inflows, Sino Biopharm, Anta, Maoyan, H&H (2019-07-19)

In our weekly HK Connect Snippet series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as...

Logo
500 Views
Share
bullish•Liaoning Port
•17 Jun 2019 12:24

HK Connect Ideas: Five Weeks of Inflows, Dalian Port Outflows (2019-06-14)

In our weekly HK Connect Snippet series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as...

Logo
656 Views
Share
x